| Walnut Creek Psychiatry | |
|
5408 Nw 88th St Ste 140 Johnston IA 50131-2953 | |
| (515) 368-7504 | |
| (515) 355-3491 |
| Full Name | Walnut Creek Psychiatry |
|---|---|
| Speciality | Nurse Practitioner |
| Location | 5408 Nw 88th St Ste 140, Johnston, Iowa |
| Authorized Official Name and Position | Hillary Chidester (OFFICE MANAGER) |
| Authorized Official Contact | 5153687504 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Walnut Creek Psychiatry 5408 Nw 88th St Ste 140 Johnston IA 50131-2953 Ph: (515) 368-7504 | Walnut Creek Psychiatry 5408 Nw 88th St Ste 140 Johnston IA 50131-2953 Ph: (515) 368-7504 |
| NPI Number | 1245833565 |
|---|---|
| Provider Enumeration Date | 11/19/2020 |
| Last Update Date | 06/01/2023 |
| Certification Date | 06/01/2023 |
| Medicare PECOS PAC ID | 5496168882 |
|---|---|
| Medicare Enrollment ID | O20210104000116 |
News Archive
Cedars-Sinai stroke intervention researchers have been informed that the National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health, will award an $8 million grant to fund a multicenter Phase II clinical trial of an experimental drug for stroke.
SARS-CoV-2 infects host cells by binding to the angiotensin convertase 2 receptor (ACE2) on the cell surface through its trimeric spike (S) protein. SARS-CoV enters host human cells through endosomes, while SARS-CoV-2 enters through the cell surface and endosomes. The present study published in the journal "Cell Reports" aimed to understand the mechanisms of SARS-CoV-2 antibody neutralization to facilitate the development of therapeutic interventions for COVID-19.
A large-scale effort to reduce childhood obesity in two low-income Massachusetts communities resulted in some modest improvements among schoolchildren over a relatively short period of time, suggesting that such a comprehensive approach holds promise for the future, according to a new study from Harvard T.H. Chan School of Public Health.
Investigators at the University of Alabama at Birmingham (UAB) have unlocked another piece of the puzzle surrounding idiopathic pulmonary fibrosis, an often fatal lung disease with no cure and no effective treatments.
MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global life sciences markets, today reported financial results for the three-month period ended July 31, 2009. MDS reported total revenue of $199 million, a net loss of $62 million and a loss per share of $0.51 for the third quarter of 2009, compared with $252 million in total revenue, a net loss of $10 million and a loss per share of $0.08 for the same period last year.
› Verified 6 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245833565 | NPI | - | NPPES |
| Provider Name | Angela J Veenstra |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1811960768 PECOS PAC ID: 7214837194 Enrollment ID: I20040109000111 |
News Archive
Cedars-Sinai stroke intervention researchers have been informed that the National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health, will award an $8 million grant to fund a multicenter Phase II clinical trial of an experimental drug for stroke.
SARS-CoV-2 infects host cells by binding to the angiotensin convertase 2 receptor (ACE2) on the cell surface through its trimeric spike (S) protein. SARS-CoV enters host human cells through endosomes, while SARS-CoV-2 enters through the cell surface and endosomes. The present study published in the journal "Cell Reports" aimed to understand the mechanisms of SARS-CoV-2 antibody neutralization to facilitate the development of therapeutic interventions for COVID-19.
A large-scale effort to reduce childhood obesity in two low-income Massachusetts communities resulted in some modest improvements among schoolchildren over a relatively short period of time, suggesting that such a comprehensive approach holds promise for the future, according to a new study from Harvard T.H. Chan School of Public Health.
Investigators at the University of Alabama at Birmingham (UAB) have unlocked another piece of the puzzle surrounding idiopathic pulmonary fibrosis, an often fatal lung disease with no cure and no effective treatments.
MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global life sciences markets, today reported financial results for the three-month period ended July 31, 2009. MDS reported total revenue of $199 million, a net loss of $62 million and a loss per share of $0.51 for the third quarter of 2009, compared with $252 million in total revenue, a net loss of $10 million and a loss per share of $0.08 for the same period last year.
› Verified 6 days ago
| Provider Name | Nicole J Topliff |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1316222185 PECOS PAC ID: 7911173687 Enrollment ID: I20111229000632 |
News Archive
Cedars-Sinai stroke intervention researchers have been informed that the National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health, will award an $8 million grant to fund a multicenter Phase II clinical trial of an experimental drug for stroke.
SARS-CoV-2 infects host cells by binding to the angiotensin convertase 2 receptor (ACE2) on the cell surface through its trimeric spike (S) protein. SARS-CoV enters host human cells through endosomes, while SARS-CoV-2 enters through the cell surface and endosomes. The present study published in the journal "Cell Reports" aimed to understand the mechanisms of SARS-CoV-2 antibody neutralization to facilitate the development of therapeutic interventions for COVID-19.
A large-scale effort to reduce childhood obesity in two low-income Massachusetts communities resulted in some modest improvements among schoolchildren over a relatively short period of time, suggesting that such a comprehensive approach holds promise for the future, according to a new study from Harvard T.H. Chan School of Public Health.
Investigators at the University of Alabama at Birmingham (UAB) have unlocked another piece of the puzzle surrounding idiopathic pulmonary fibrosis, an often fatal lung disease with no cure and no effective treatments.
MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global life sciences markets, today reported financial results for the three-month period ended July 31, 2009. MDS reported total revenue of $199 million, a net loss of $62 million and a loss per share of $0.51 for the third quarter of 2009, compared with $252 million in total revenue, a net loss of $10 million and a loss per share of $0.08 for the same period last year.
› Verified 6 days ago
| Provider Name | Holly J Lukasiewicz |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1669887469 PECOS PAC ID: 6406122118 Enrollment ID: I20171025001097 |
News Archive
Cedars-Sinai stroke intervention researchers have been informed that the National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health, will award an $8 million grant to fund a multicenter Phase II clinical trial of an experimental drug for stroke.
SARS-CoV-2 infects host cells by binding to the angiotensin convertase 2 receptor (ACE2) on the cell surface through its trimeric spike (S) protein. SARS-CoV enters host human cells through endosomes, while SARS-CoV-2 enters through the cell surface and endosomes. The present study published in the journal "Cell Reports" aimed to understand the mechanisms of SARS-CoV-2 antibody neutralization to facilitate the development of therapeutic interventions for COVID-19.
A large-scale effort to reduce childhood obesity in two low-income Massachusetts communities resulted in some modest improvements among schoolchildren over a relatively short period of time, suggesting that such a comprehensive approach holds promise for the future, according to a new study from Harvard T.H. Chan School of Public Health.
Investigators at the University of Alabama at Birmingham (UAB) have unlocked another piece of the puzzle surrounding idiopathic pulmonary fibrosis, an often fatal lung disease with no cure and no effective treatments.
MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global life sciences markets, today reported financial results for the three-month period ended July 31, 2009. MDS reported total revenue of $199 million, a net loss of $62 million and a loss per share of $0.51 for the third quarter of 2009, compared with $252 million in total revenue, a net loss of $10 million and a loss per share of $0.08 for the same period last year.
› Verified 6 days ago
| Provider Name | Lorraine Chidester |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1477019446 PECOS PAC ID: 6305259797 Enrollment ID: I20210104000201 |
News Archive
Cedars-Sinai stroke intervention researchers have been informed that the National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health, will award an $8 million grant to fund a multicenter Phase II clinical trial of an experimental drug for stroke.
SARS-CoV-2 infects host cells by binding to the angiotensin convertase 2 receptor (ACE2) on the cell surface through its trimeric spike (S) protein. SARS-CoV enters host human cells through endosomes, while SARS-CoV-2 enters through the cell surface and endosomes. The present study published in the journal "Cell Reports" aimed to understand the mechanisms of SARS-CoV-2 antibody neutralization to facilitate the development of therapeutic interventions for COVID-19.
A large-scale effort to reduce childhood obesity in two low-income Massachusetts communities resulted in some modest improvements among schoolchildren over a relatively short period of time, suggesting that such a comprehensive approach holds promise for the future, according to a new study from Harvard T.H. Chan School of Public Health.
Investigators at the University of Alabama at Birmingham (UAB) have unlocked another piece of the puzzle surrounding idiopathic pulmonary fibrosis, an often fatal lung disease with no cure and no effective treatments.
MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global life sciences markets, today reported financial results for the three-month period ended July 31, 2009. MDS reported total revenue of $199 million, a net loss of $62 million and a loss per share of $0.51 for the third quarter of 2009, compared with $252 million in total revenue, a net loss of $10 million and a loss per share of $0.08 for the same period last year.
› Verified 6 days ago
| Provider Name | Erin L Fox-hammel |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1609532373 PECOS PAC ID: 1850784331 Enrollment ID: I20220204000883 |
News Archive
Cedars-Sinai stroke intervention researchers have been informed that the National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health, will award an $8 million grant to fund a multicenter Phase II clinical trial of an experimental drug for stroke.
SARS-CoV-2 infects host cells by binding to the angiotensin convertase 2 receptor (ACE2) on the cell surface through its trimeric spike (S) protein. SARS-CoV enters host human cells through endosomes, while SARS-CoV-2 enters through the cell surface and endosomes. The present study published in the journal "Cell Reports" aimed to understand the mechanisms of SARS-CoV-2 antibody neutralization to facilitate the development of therapeutic interventions for COVID-19.
A large-scale effort to reduce childhood obesity in two low-income Massachusetts communities resulted in some modest improvements among schoolchildren over a relatively short period of time, suggesting that such a comprehensive approach holds promise for the future, according to a new study from Harvard T.H. Chan School of Public Health.
Investigators at the University of Alabama at Birmingham (UAB) have unlocked another piece of the puzzle surrounding idiopathic pulmonary fibrosis, an often fatal lung disease with no cure and no effective treatments.
MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global life sciences markets, today reported financial results for the three-month period ended July 31, 2009. MDS reported total revenue of $199 million, a net loss of $62 million and a loss per share of $0.51 for the third quarter of 2009, compared with $252 million in total revenue, a net loss of $10 million and a loss per share of $0.08 for the same period last year.
› Verified 6 days ago
| Provider Name | Haley Lynn Kloberdanz |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1104553304 PECOS PAC ID: 6901267988 Enrollment ID: I20230808000251 |
News Archive
Cedars-Sinai stroke intervention researchers have been informed that the National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health, will award an $8 million grant to fund a multicenter Phase II clinical trial of an experimental drug for stroke.
SARS-CoV-2 infects host cells by binding to the angiotensin convertase 2 receptor (ACE2) on the cell surface through its trimeric spike (S) protein. SARS-CoV enters host human cells through endosomes, while SARS-CoV-2 enters through the cell surface and endosomes. The present study published in the journal "Cell Reports" aimed to understand the mechanisms of SARS-CoV-2 antibody neutralization to facilitate the development of therapeutic interventions for COVID-19.
A large-scale effort to reduce childhood obesity in two low-income Massachusetts communities resulted in some modest improvements among schoolchildren over a relatively short period of time, suggesting that such a comprehensive approach holds promise for the future, according to a new study from Harvard T.H. Chan School of Public Health.
Investigators at the University of Alabama at Birmingham (UAB) have unlocked another piece of the puzzle surrounding idiopathic pulmonary fibrosis, an often fatal lung disease with no cure and no effective treatments.
MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global life sciences markets, today reported financial results for the three-month period ended July 31, 2009. MDS reported total revenue of $199 million, a net loss of $62 million and a loss per share of $0.51 for the third quarter of 2009, compared with $252 million in total revenue, a net loss of $10 million and a loss per share of $0.08 for the same period last year.
› Verified 6 days ago
| Provider Name | Miranda Engeldinger |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1699456087 PECOS PAC ID: 6406210079 Enrollment ID: I20230914003512 |
News Archive
Cedars-Sinai stroke intervention researchers have been informed that the National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health, will award an $8 million grant to fund a multicenter Phase II clinical trial of an experimental drug for stroke.
SARS-CoV-2 infects host cells by binding to the angiotensin convertase 2 receptor (ACE2) on the cell surface through its trimeric spike (S) protein. SARS-CoV enters host human cells through endosomes, while SARS-CoV-2 enters through the cell surface and endosomes. The present study published in the journal "Cell Reports" aimed to understand the mechanisms of SARS-CoV-2 antibody neutralization to facilitate the development of therapeutic interventions for COVID-19.
A large-scale effort to reduce childhood obesity in two low-income Massachusetts communities resulted in some modest improvements among schoolchildren over a relatively short period of time, suggesting that such a comprehensive approach holds promise for the future, according to a new study from Harvard T.H. Chan School of Public Health.
Investigators at the University of Alabama at Birmingham (UAB) have unlocked another piece of the puzzle surrounding idiopathic pulmonary fibrosis, an often fatal lung disease with no cure and no effective treatments.
MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global life sciences markets, today reported financial results for the three-month period ended July 31, 2009. MDS reported total revenue of $199 million, a net loss of $62 million and a loss per share of $0.51 for the third quarter of 2009, compared with $252 million in total revenue, a net loss of $10 million and a loss per share of $0.08 for the same period last year.
› Verified 6 days ago
| Provider Name | Kirsten Just |
|---|---|
| Provider Type | Practitioner - Marriage And Family Therapist |
| Provider Identifiers | NPI Number: 1447684865 PECOS PAC ID: 6002264249 Enrollment ID: I20231128002380 |
News Archive
Cedars-Sinai stroke intervention researchers have been informed that the National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health, will award an $8 million grant to fund a multicenter Phase II clinical trial of an experimental drug for stroke.
SARS-CoV-2 infects host cells by binding to the angiotensin convertase 2 receptor (ACE2) on the cell surface through its trimeric spike (S) protein. SARS-CoV enters host human cells through endosomes, while SARS-CoV-2 enters through the cell surface and endosomes. The present study published in the journal "Cell Reports" aimed to understand the mechanisms of SARS-CoV-2 antibody neutralization to facilitate the development of therapeutic interventions for COVID-19.
A large-scale effort to reduce childhood obesity in two low-income Massachusetts communities resulted in some modest improvements among schoolchildren over a relatively short period of time, suggesting that such a comprehensive approach holds promise for the future, according to a new study from Harvard T.H. Chan School of Public Health.
Investigators at the University of Alabama at Birmingham (UAB) have unlocked another piece of the puzzle surrounding idiopathic pulmonary fibrosis, an often fatal lung disease with no cure and no effective treatments.
MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global life sciences markets, today reported financial results for the three-month period ended July 31, 2009. MDS reported total revenue of $199 million, a net loss of $62 million and a loss per share of $0.51 for the third quarter of 2009, compared with $252 million in total revenue, a net loss of $10 million and a loss per share of $0.08 for the same period last year.
› Verified 6 days ago
| Provider Name | Samantha Alexis Rodriguez |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1629696893 PECOS PAC ID: 1355790692 Enrollment ID: I20231212000462 |
News Archive
Cedars-Sinai stroke intervention researchers have been informed that the National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health, will award an $8 million grant to fund a multicenter Phase II clinical trial of an experimental drug for stroke.
SARS-CoV-2 infects host cells by binding to the angiotensin convertase 2 receptor (ACE2) on the cell surface through its trimeric spike (S) protein. SARS-CoV enters host human cells through endosomes, while SARS-CoV-2 enters through the cell surface and endosomes. The present study published in the journal "Cell Reports" aimed to understand the mechanisms of SARS-CoV-2 antibody neutralization to facilitate the development of therapeutic interventions for COVID-19.
A large-scale effort to reduce childhood obesity in two low-income Massachusetts communities resulted in some modest improvements among schoolchildren over a relatively short period of time, suggesting that such a comprehensive approach holds promise for the future, according to a new study from Harvard T.H. Chan School of Public Health.
Investigators at the University of Alabama at Birmingham (UAB) have unlocked another piece of the puzzle surrounding idiopathic pulmonary fibrosis, an often fatal lung disease with no cure and no effective treatments.
MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global life sciences markets, today reported financial results for the three-month period ended July 31, 2009. MDS reported total revenue of $199 million, a net loss of $62 million and a loss per share of $0.51 for the third quarter of 2009, compared with $252 million in total revenue, a net loss of $10 million and a loss per share of $0.08 for the same period last year.
› Verified 6 days ago
News Archive
Cedars-Sinai stroke intervention researchers have been informed that the National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health, will award an $8 million grant to fund a multicenter Phase II clinical trial of an experimental drug for stroke.
SARS-CoV-2 infects host cells by binding to the angiotensin convertase 2 receptor (ACE2) on the cell surface through its trimeric spike (S) protein. SARS-CoV enters host human cells through endosomes, while SARS-CoV-2 enters through the cell surface and endosomes. The present study published in the journal "Cell Reports" aimed to understand the mechanisms of SARS-CoV-2 antibody neutralization to facilitate the development of therapeutic interventions for COVID-19.
A large-scale effort to reduce childhood obesity in two low-income Massachusetts communities resulted in some modest improvements among schoolchildren over a relatively short period of time, suggesting that such a comprehensive approach holds promise for the future, according to a new study from Harvard T.H. Chan School of Public Health.
Investigators at the University of Alabama at Birmingham (UAB) have unlocked another piece of the puzzle surrounding idiopathic pulmonary fibrosis, an often fatal lung disease with no cure and no effective treatments.
MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global life sciences markets, today reported financial results for the three-month period ended July 31, 2009. MDS reported total revenue of $199 million, a net loss of $62 million and a loss per share of $0.51 for the third quarter of 2009, compared with $252 million in total revenue, a net loss of $10 million and a loss per share of $0.08 for the same period last year.
› Verified 6 days ago
Deena Leonard, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 7328 Moonlight Dr, Johnston, IA 50131 Phone: 515-210-4701 | |
Ashby Psychological Services, Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 5415 Nw 88th St, Johnston, IA 50131 Phone: 515-727-1338 | |
Childserve Clinics Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 5406 Merle Hay Rd, Johnston, IA 50131 Phone: 515-727-8750 Fax: 515-727-8757 | |
Self Discoveries Plc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 6165 Nw 86th St, Johnston, IA 50131 Phone: 515-978-1305 | |
Heartland Aea 11 Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 6500 Corporate Drive, Johnston, IA 50131 Phone: 515-270-9030 Fax: 515-270-5383 | |
Red Couch Counseling Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 6165 Nw 86th St, Johnston, IA 50131 Phone: 515-954-9865 | |
Tappe & Sanchez Support Services, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 7044 Carey Ct, Johnston, IA 50131 Phone: 515-745-5448 Fax: 515-864-0320 |